GPIaIIa as a candidate target for anti-platelet autoantibody occurring during valproate therapy and associated with peroperative bleeding.
Proulle
V
V
Masnou
P
P
Cartron
J
J
Kaplan
C
C
Ajzenberg
N
N
Tchernia
G
G
Dreyfus
M
M
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001254:Astrocytoma / Q000188:drug therapy; D001323:Autoantibodies / Q000276:immunology*; D001792:Blood Platelets / Q000276:immunology*; D001932:Brain Neoplasms / Q000188:drug therapy; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000276:immunology*; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced*; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000276:immunology; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D001323:Autoantibodies; D019038:Platelet Glycoprotein GPIb-IX Complex; D014635:Valproic Acid